1. Home
  2. NVCR vs WULF Comparison

NVCR vs WULF Comparison

Compare NVCR & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • WULF
  • Stock Information
  • Founded
  • NVCR 2000
  • WULF 1952
  • Country
  • NVCR Switzerland
  • WULF United States
  • Employees
  • NVCR N/A
  • WULF N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • WULF EDP Services
  • Sector
  • NVCR Health Care
  • WULF Technology
  • Exchange
  • NVCR Nasdaq
  • WULF Nasdaq
  • Market Cap
  • NVCR 1.9B
  • WULF 1.8B
  • IPO Year
  • NVCR 2015
  • WULF 1995
  • Fundamental
  • Price
  • NVCR $17.71
  • WULF $5.23
  • Analyst Decision
  • NVCR Buy
  • WULF Strong Buy
  • Analyst Count
  • NVCR 6
  • WULF 9
  • Target Price
  • NVCR $32.83
  • WULF $8.22
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • WULF 52.1M
  • Earning Date
  • NVCR 07-24-2025
  • WULF 08-11-2025
  • Dividend Yield
  • NVCR N/A
  • WULF N/A
  • EPS Growth
  • NVCR N/A
  • WULF N/A
  • EPS
  • NVCR N/A
  • WULF N/A
  • Revenue
  • NVCR $621,711,000.00
  • WULF $132,023,000.00
  • Revenue This Year
  • NVCR $5.56
  • WULF $44.72
  • Revenue Next Year
  • NVCR $9.19
  • WULF $85.27
  • P/E Ratio
  • NVCR N/A
  • WULF N/A
  • Revenue Growth
  • NVCR 18.27
  • WULF 31.85
  • 52 Week Low
  • NVCR $14.17
  • WULF $2.06
  • 52 Week High
  • NVCR $34.13
  • WULF $9.30
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.32
  • WULF 68.82
  • Support Level
  • NVCR $17.53
  • WULF $3.70
  • Resistance Level
  • NVCR $18.70
  • WULF $4.53
  • Average True Range (ATR)
  • NVCR 0.72
  • WULF 0.38
  • MACD
  • NVCR 0.09
  • WULF 0.10
  • Stochastic Oscillator
  • NVCR 60.56
  • WULF 90.58

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: